Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure;Valor pronóstico de las cifras de hemoglobina en el momento del alta en pacientes hospitalizados por insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 59, Issue 12, 2006, Pages 1276-1282

  Sánchez Torrijos, Jorge ^a   Gudín Uriel, Margarita ^a   Nadal Barangé, Mercedes ^a   Jacas Osborn, Victoria ^a   Trigo Bautista, Alberto ^a   Giménez Alcalá, Mónica ^a   Payá Serrano, Rafael ^a   Ridocci Soriano, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Heart failure; Hemoglobin; Prognosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; AGED; ANEMIA; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DISEASE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

EID: 33846680587     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13096601     Document Type: Article

References (32)

1. Rodríguez-Artalejo F, Benegas-Benegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol. 2004;57:163-70.
2. American Heart Association. Heart Disease and Stroke Statistics-2006 Update. Dallas: American Heart Association; 2006.
3. Roig E. La anemia en la insuficiencia cardiaca. ¿Es un marcador de gravedad o un objetivo terapéutico? Rev Esp Cardiol. 2005; 58:10-2.
4. Wexler D, Silverberg D, Sheps D, Blum M, Keren G, Iaina A, et al. Prevalence of anemia in patients admitted to hospital with a primary diagnostic of congestive heart failure. Int J Cardiol. 2004:96:79-87.
5. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiiffner D, Hess OM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 2002;86:115-21.
6. Urrutia A, Lupón J, González B, Pajarón T, Altimir S, Coll R, et al. Anemia y parámetros relacionados en pacientes de una unidad de insuficiencia cardiaca multidisciplinaria. Med Clin (Barc). 2004;122:121-5.
7. Van der Meer P, Van Gilst WH, van Veldhuisen DJ. Anemia and congestive heart failure. Circulation. 2003;12;108:e41-2.
8. Ezekowitz JA, McAlister FA, Amstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
9. Al-Ahmad, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS et al. Reduced kidney function and anemia as risk factor for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-62.
10. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: The Prospective randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cadiol. 2003;41:1933-9.
11. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenestin J. Anemia is associated with worse symptoms, greater impairment in funtional capacity and significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-6.
12. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-9.
13. Kalra PR, Collier T, Cowie MR, Fox KF, Poole-Wilson PA, Coats AJ, et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet. 2003;362:211-2.
14. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-8.
15. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarec A, Reczuch K, Kalra PR, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 2003;90:303-8.
16. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:223-5.
17. Sharma R, Darrel PF, Pitt B, Poole Wilson PA, Coats AJS, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: substudy of the ELITE II trial. Eur Heart J. 2004;25: 1021-8.
18. Brucks S, Little WC, Chao T, Rideman RL, Upadhya B, Wesley-Farrington D. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol. 2004;93:1055-7.
19. Maggioni AP, Opasich C, Anand I, Barlera S, Carbonieri E, Gonzini L, et al. Anemia in patients with heart failure: Prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail. 2004;11:91-8.
20. Anand I, McMurray JJV, Whitmore J, Warren M, Pham A, McCarnish MA et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149-54.
21. Komajda M. Prevalence of anemia in patients with chronic heart failure an their clinical characteristics. J Card Fail. 2004;10 Suppl 1:1-4.
22. Foley RN, Parfrey PS, Harnett JD, Kent G, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61.
23. Anker SD, Sharma R, Francis D. Anemia and survival in 3044 patients with chronic heart failure in the ELITE II Study (abstract). Circulation. 2002;106 Suppl:2335.
24. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail. 2004;10:467-72.
25. Lupón J, Urrutia A, González B, Herreros J, Altimir S, Coll R, et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardiaca. Rev Esp Cardiol. 2005;58:48-53.
26. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM et al. Anemia and outcomes in patients with heart failure. A study from the National Heart Care Project. Arch Intern Med. 2005;165:2237-44.
27. Grigorian-Shamagian L, Varela-Román A, Mazón-Ramos P, Pradeira-Pérez M, Regueiro-Veloso P, González-Juanatey JR. Anemia como nuevo predictor de la mortalidad de pacientes hospitalizados por insuficiencia cardiaca congestiva. Med Clin (Barc). 2005;125:647-52.
28. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-44.
29. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erytropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol. 2001;37:1775-80.
30. Mancini DM, Katz S, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-9.
31. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J. 2005;149:391-401.
32. Grigorian L, Varela A, García-Acuña JM, Mazón P, Virgos A, González Juanatey JR. Anemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart. 2006;92:780-4.